Leptomeningeal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-04
Clinical Trial Update: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer [Phase 2]
Phase 2 trial of iodine-131 monoclonal antibody 3F8 in CNS and leptomeningeal cancers completed; results posted.